High‐dose bendamustine plus brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma. (June 2017)

Record Type:: Journal Article
Title:: High‐dose bendamustine plus brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma. (June 2017)
Main Title:: High‐dose bendamustine plus brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma
Authors:: Cerchione, C.
Di Perna, M.
Della Pepa, R.
Pugliese, N.
Pane, F.
Picardi, M.
Abstract:
Is Part Of:: Hematological oncology. Volume 35(2017)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 35(2017)Supplement 2
Issue Display:: Volume 35, Issue 2 (2017)
Year:: 2017
Volume:: 35
Issue:: 2
Issue Sort Value:: 2017-0035-0002-0000
Page Start:: 317
Page End:: 318
Publication Date:: 2017-06
Subjects:: Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.2439_58 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 1269.xml